Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ahmed Ali, Mervat EL-Aziz, Ahmed Abdelhafez, Amr Thabet (2022)
Effect of Oral Vasopressors Used for Liberation from Intravenous Vasopressors in Intensive Care Unit Patients Recovering from Spinal Shock: A Randomized Controlled TrialCritical Care Research and Practice, 2022
B. Levy, C. Fritz, Elsa Tahon, Audrey Jacquot, T. Auchet, A. Kimmoun (2018)
Vasoplegia treatments: the past, the present, and the futureCritical Care, 22
A. Lal, Vrinda Trivedi, Mahrukh Rizvi, Amy Amsbaugh, Melissa Myers, K. Saleh, R. Kashyap, O. Gajic (2021)
Oral Midodrine Administration During the First 24 Hours of Sepsis to Reduce the Need of Vasoactive Agents: Placebo-Controlled Feasibility Clinical TrialCritical Care Explorations, 3
P. Santer, M. Anstey, M. Patrocínio, B. Wibrow, B. Teja, D. Shay, S. Shaefi, Charles Parsons, T. Houle, M. Eikermann, Peter P, P. Santer, M. Anstey, M. Patrocínio, B. Wibrow, B. Teja, D. Shay, S. Shaefi, Charles Parsons, T. Houle, M. Eikermann, Kwok Ho, S. Schaller, T. Thevathasan, L. Albrecht, S. Grabitz, Khushi Chhangani, P. Ng, Alexander Levine, A. DiBiasio, Robert Palmer, E. Myers, R. Rauniyar, T. Sarge, F. Scheffenbichler, Alok Gupta (2020)
Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trialIntensive Care Medicine, 46
A. Parsaik, Balwinder Singh, Osama Altayar, S. Rn, Shannon Singh, P. Erwin, Mph MD (2013)
Midodrine for Orthostatic Hypotension: A Systematic Review and Meta-Analysis of Clinical TrialsJournal of General Internal Medicine, 28
Drayton Hammond, Melanie Smith, G. Peksa, A. Trivedi, R. Balk, Bryan Menich (2020)
Midodrine as an Adjuvant to Intravenous Vasopressor Agents in Adults With Resolving Shock: Systematic Review and Meta-AnalysisJournal of Intensive Care Medicine, 35
M. Müllner, B. Urbanek, C. Havel, H. Losert, G. Gamper, H. Herkner (2004)
Vasopressors for shock.The Cochrane database of systematic reviews, 3
Müllner (2004)
Cd003709Cochrane Database Syst Rev, 3
Rahul Costa-Pinto, Z. Yong, Fumitaka Yanase, C. Young, Alastair Brown, A. Udy, P. Young, G. Eastwood, R. Bellomo (2021)
A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study.Journal of critical care, 67
Ahmad Al-Abdouh, Sadam Haddadin, A. Matta, A. Jabri, Mahmoud Barbarawi, W. Abusnina, Q. Radideh, M. Mhanna, Dante Suffredini, E. Michos (2021)
Impact of Adjuvant Use of Midodrine to Intravenous Vasopressors: A Systematic Review and Meta-AnalysisCritical Care Research and Practice, 2021
Dina Adly, N. Bazan, Radwa Borolossy, I. Anan, M. Fakher, L. Wakeel (2022)
Midodrine improves clinical and economic outcomes in patients with septic shock: a randomized controlled clinical trialIrish Journal of Medical Science (1971 -)
S. Kohsaka, V. Menon, A. Lowe, M. Lange, V. Džavík, L. Sleeper, J. Hochman (2005)
Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.Archives of internal medicine, 165 14
S. Prakash, A. Garg, A. Heidenheim, A. House (2004)
Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19 10
T. Baker, Jacqueline Romero, H. Bach, J. Strom, R. Gamelli, M. Majetschak (2012)
Systemic release of cytokines and heat shock proteins in porcine models of polytrauma and hemorrhage*Critical Care Medicine, 40
e274 Letters to the Editor pulmonary aspergillosis(1). Emerg Infect Dis. 2021;27: 26. Huang L, Zhang N, Huang X, et al. Invasive pulmonary 2892–2898. aspergillosis in patients with influenza infection: a retro- 20. Kim SH, Hong JY, Bae S, et al. Risk factors for coronavi- spective study and review of the literature. Clin Respir J. rus disease 2019 (COVID-19)-Associated pulmonary 2019;13:202–211. aspergillosis in critically ill patients: a nationwide, mul- 27. Ali ZA, Ali A, Tempest M, et al. Invasive pulmonary ticenter, retrospective cohort study. J Korean Med Sci. aspergillosis complicating chronic obstructive pulmo- 2022;37:e134. nary disease in an immunocompetent patient. 21. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and J Postgrad Med. 2003;49:78–80. managing COVID-19-associated pulmonary aspergillosis: 28. Cicek N, Yildiz N, Kadayifci EK, et al. Invasive aspergil- the 2020 ECMM/ISHAM consensus criteria for research losis in a patient with end stage renal disease. Med Mycol and clinical guidance. Lancet Infect Dis. 2021;21:e149–e162. Case Rep. 2017;18:12–14. 22. Mitaka H, Kuno T, Takagi H, et al. Incidence and mor- 29. Stevens DA, Melikian GL. Aspergillosis in the ‘nonimmu- tality of COVID-19-associated pulmonary aspergillosis: nocompromised’ host. Immunol Invest. 2011;40:751–766. a systematic review and meta-analysis. Mycoses. 2021; 30. Sahlen AO, Suvarna
American Journal of Therapeutics – Wolters Kluwer Health
Published: Feb 28, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.